171 related articles for article (PubMed ID: 36221980)
1. Evaluation of simple laboratory parameters in SARS-CoV-2 infection: the role of ratios.
Oblitas CM; Galeano-Valle F; Cuenca-Carvajal C; Piqueras-Ruiz S; Alonso-Beato R; Alejandre-de-Oña Á; Carrascosa-Fernández P; Chacón Moreno AD; Parra-Virto A; Pérez Sanz MT; Abarca Casas L; Millán-Nohales C; Álvarez-Sala-Walther L; Demelo-Rodríguez P
Infect Dis (Lond); 2022 Dec; 54(12):924-933. PubMed ID: 36221980
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of Interleukin-6/lymphocytes ratio in SARS-CoV2 related pneumonia.
Masotti L; Grifoni E; Pelagalli G; Cioni E; Mattaliano C; Cioffi E; Maggi F; Pinto G; Madonia EM; Micheletti I; Gelli AMG; Ciambotti B; Mannucci A; Bello R; Cei F; Dolenti S; Tarquini R; Montenora I; Spina R; Vanni S
Int Immunopharmacol; 2022 Feb; 103():108435. PubMed ID: 34920336
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National Cohort.
Oblitas CM; Demelo-Rodríguez P; Alvarez-Sala-Walther LA; Rubio-Rivas M; Navarro-Romero F; Giner Galvañ V; de Jorge-Huerta L; Fonseca Aizpuru E; García García GM; Beato Pérez JL; Pesqueira Fontan PM; Artero Mora A; Vargas Núñez JA; Ramírez Perea N; García Bruñén JM; Roy Vallejo E; Perales-Fraile I; Gil Sánchez R; López Castro J; Martínez González ÁL; Díez García LF; Aroza Espinar M; Casas-Rojo JM; Millán Núñez-Cortés J;
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543700
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry.
Khedar RS; Gupta R; Sharma K; Mittal K; Ambaliya HC; Gupta JB; Singh S; Sharma S; Singh Y; Mathur A
BMJ Open; 2022 Dec; 12(12):e067430. PubMed ID: 36521904
[TBL] [Abstract][Full Text] [Related]
6. Association between platelet indices and the severity of the disease and mortality in patients with COVID-19.
Yardımcı AC; Yıldız S; Ergen E; Ballı H; Ergene E; Guner YS; Karnap M; Demırbas Keskın D; Yuksel H; Bocutoglu F; Akbel VC; Kalyoncu D
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6731-6740. PubMed ID: 34787878
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 severity appears to be reduced in spring/summer.
Sposato B; Serafini A; Simoncini E; Croci L; Guidoni C; Scalese M; Baratta P; Cresti A; Lacerenza LG; Lena F; Nencioni C; Spargi G; Perrella A;
Epidemiol Prev; 2023; 47(1-2):34-46. PubMed ID: 36971236
[TBL] [Abstract][Full Text] [Related]
8. [Investigation of the Relationship of Systemic Immune-Inflammation Index, C-Reactive Protein and Interleukin-6 with Viral Dynamics in Patients with COVID-19].
Salman E; Çelikbilek N; Aydoğan S; Özdem B; Gökay S; Kırca F; Toyran A; Bilici Salman R; Dinç B
Mikrobiyol Bul; 2021 Oct; 55(4):539-552. PubMed ID: 34666654
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal changes in inflammatory biomarkers among patients with COVID-19: A nationwide study in Iceland.
Oskarsdottir T; Sigurdsson MI; Palsson R; Eythorsson E
Acta Anaesthesiol Scand; 2022 Sep; 66(8):969-977. PubMed ID: 35748857
[TBL] [Abstract][Full Text] [Related]
10. Investigating Biomarkers for COVID-19 Morbidity and Mortality.
Ceci FM; Ferraguti G; Lucarelli M; Angeloni A; Bonci E; Petrella C; Francati S; Barbato C; Di Certo MG; Gabanella F; Gavaruzzi F; Mastroianni CM; Minni A; Greco A; Ralli M; Ceccanti M; Tarani L; Fiore M
Curr Top Med Chem; 2023; 23(13):1196-1210. PubMed ID: 36815637
[TBL] [Abstract][Full Text] [Related]
11. Routine laboratory parameters in estimating mortality and morbidity in COVID-19 diagnosed cases followed in the intensive care unit.
Kutlusoy S; Koca E
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5885-5892. PubMed ID: 37401326
[TBL] [Abstract][Full Text] [Related]
12. The novel biomarker, neopterin, can predict the severity of COVID-19.
Karacaer C; Yaylaci S; Issever K; Sert H; Suner KO; Cokluk E; Nalbant A; Demirci T; Varim C; Kaya T
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5568-5573. PubMed ID: 35993654
[TBL] [Abstract][Full Text] [Related]
13. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans.
Ashktorab H; Pizuorno A; Adeleye F; Laiyemo A; Dalivand MM; Aduli F; Sherif ZA; Oskrochi G; Angesom K; Oppong-Twene P; Challa SR; Okorie N; Moon ES; Romos E; Jones-Wonni B; Kone AM; Rankine S; Thrift C; Scholes D; Ekwunazu C; Banson A; Mitchell B; Maskalo G; Ross J; Curtis J; Kim R; Gilliard C; Ahuja G; Mathew J; Gavin W; Kara A; Hache-Marliere M; Palaiodimos L; Mani VR; Kalabin A; Gayam VR; Garlapati PR; Miller J; Chirumamilla LG; Jackson F; Carethers JM; Kamangar F; Brim H
BMC Infect Dis; 2022 Jun; 22(1):552. PubMed ID: 35715729
[TBL] [Abstract][Full Text] [Related]
15. Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.
Bolondi G; Russo E; Gamberini E; Circelli A; Meca MCC; Brogi E; Viola L; Bissoni L; Poletti V; Agnoletti V
World J Emerg Surg; 2020 Jun; 15(1):41. PubMed ID: 32605582
[TBL] [Abstract][Full Text] [Related]
16. Early predictors for mechanical ventilation in COVID-19 patients.
Li W; Lin F; Dai M; Chen L; Han D; Cui Y; Pan P
Ther Adv Respir Dis; 2020; 14():1753466620963017. PubMed ID: 33054630
[TBL] [Abstract][Full Text] [Related]
17. Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study.
Mousavi SA; Rad S; Rostami T; Rostami M; Mousavi SA; Mirhoseini SA; Kiumarsi A
Hematology; 2020 Dec; 25(1):383-388. PubMed ID: 33124971
[No Abstract] [Full Text] [Related]
18. Retrospective Cohort Observational Study to compare the Effect of Mycobacterium w along with Standard of Care vs Standard of Care alone in critically ill COVID-19 Patients.
Dixit S; Zirpe K; Suryawanshi P; Borawake K; Prasad S; Ambapkar S; Ambapkar S; Joshi A; Joshi M
J Assoc Physicians India; 2022 Jul; 70(7):11-12. PubMed ID: 35833395
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Viremia is Associated With Inflammatory, But Not Cardiovascular Biomarkers, in Patients Hospitalized for COVID-19.
Myhre PL; Prebensen C; Jonassen CM; Berdal JE; Omland T
J Am Heart Assoc; 2021 May; 10(9):e019756. PubMed ID: 33596668
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
